Oral and gut dysbiosis leads to functional alterations in Parkinson's disease/Experiment 4

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2024-7-3

Curated date: 2024/03/29

Curator: Idiaru angela

Revision editor(s): Idiaru angela

Subjects

Location of subjects
South Korea
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Parkinson's disease IDIOPATHIC PARKINSON DIS,Idiopathic Parkinson Disease,Idiopathic Parkinson's Disease,IDIOPATHIC PARKINSONS DIS,Idiopathic PD,LEWY BODY PARKINSON DIS,Lewy Body Parkinson Disease,Lewy Body Parkinson's Disease,Paralysis agitans,paralysis agitans,PARKINSON DIS,PARKINSON DIS IDIOPATHIC,Parkinson disease,Parkinson Disease, Idiopathic,Parkinson syndrome,Parkinson's,Parkinson's disease,Parkinson's disease (disorder),Parkinson's disease NOS,Parkinson's disease NOS (disorder),Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinson's syndrome,Parkinsonian disorder,Parkinsonism, Primary,Parkinsons,PARKINSONS DIS,PARKINSONS DIS IDIOPATHIC,PARKINSONS DIS LEWY BODY,Parkinsons disease,Primary Parkinsonism,parkinson's disease
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy controls (HC)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Patients with Parkinson's Disease (PD)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with Parkinson's disease enrolled using the UK PD Society brain bank clinical diagnostic criteria.
Group 0 sample size Number of subjects in the control (unexposed) group
84
Group 1 sample size Number of subjects in the case (exposed) group
88
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
participants using antibiotics

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
unchanged

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-7-3

Curated date: 2024/03/30

Curator: Idiaru angela

Revision editor(s): Idiaru angela

Source: figure 1e & text in paragraph 4, page 4

Description: Comparison of the gut microbiome between PD and HCs using genus level LEfSe analysis.

Abundance in Group 1: increased abundance in Patients with Parkinson's Disease (PD)

NCBI Quality ControlLinks
Alistipes
Bifidobacterium
Collinsella
Escherichia
Hungatella
Lactobacillus
Mogibacterium
Odoribacter
Oscillibacter
Parabacteroides
Sporobacter
PAC001115PAC001115
Eubacterim_g23Eubacterim_g23
PAC000661PAC000661

Revision editor(s): Idiaru angela

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2024-7-3

Curated date: 2024/03/30

Curator: Idiaru angela

Revision editor(s): Idiaru angela

Source: figure 1e

Description: Comparison of gut microbiome between PD and HCs using genus level LEfSe analysis.

Abundance in Group 1: decreased abundance in Patients with Parkinson's Disease (PD)

NCBI Quality ControlLinks
Agathobacter
Coprococcus
Enterococcus
Haemophilus
Prevotella
Roseburia
Ruminococcus
LLKBLLKB
PAC001043PAC001043
PAC001032PAC001032

Revision editor(s): Idiaru angela